Ryan White HIV/AIDS Program Part D -- Women, Infants, Children, and Youth (WICY) Grants Supplemental Funding | HRSA 19 026

Opportunity Information: Apply for HRSA 19 026

The Ryan White HIV/AIDS Program (RWHAP) Part D Women, Infants, Children, and Youth (WICY) Grants Supplemental Funding opportunity (HRSA-19-026) was a fiscal year 2019 discretionary grant competition run by the U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA). It offered supplemental funding to existing Part D programs focused on women, infants, children, and youth living with HIV, with an emphasis on improving access to high quality, family-centered HIV primary health care for people who are low income, uninsured, or otherwise underserved. The overarching aim was to help Part D recipients strengthen their organizational capacity in response to a shifting health care environment, while also improving outcomes along the HIV care continuum.

A key feature of this supplemental was its narrow and time-limited scope: applicants were expected to propose one short-term activity that could be completed within a one-year period of performance. Rather than funding broad program expansions, HRSA designed this as a targeted infusion to implement a discrete, achievable project that measurably improves service delivery, engagement in care, retention, adherence, or related system capabilities that support better clinical outcomes for people living with HIV.

The supplemental centered on "HIV Care Innovation" activities, intended to move programs forward on the HIV care continuum in ways that improve health and longevity for people living with HIV and reduce new infections. Applicants had to choose from five defined activity options: (1) patient-based treatment adherence, (2) motivational interviewing, (3) transitioning youth into adult HIV care, (4) intimate partner violence screening and counseling, and (5) youth stable housing collaboration. These options reflect HRSA's interest in practical, evidence-informed strategies that improve linkage and retention in care, strengthen adherence support, address barriers that commonly disrupt care (including violence and housing instability), and reduce drop-off during major life transitions such as moving from pediatric/adolescent services to adult care settings.

HRSA also made clear that funded activities should be aligned with broader HHS and HRSA priority areas, including stronger collaboration across systems and attention to intersecting public health challenges such as the opioid crisis and mental health needs. In practice, that meant applicants needed to show how their chosen activity would not only serve WICY clients directly, but also build sustainable internal capacity such as improved workflows, staff skills, partnerships, screening practices, or care coordination approaches that help the organization respond more effectively to complex client needs.

For prior awardees, the notice included specific restrictions and a pathway for building on earlier work. Programs that received FY 2018 supplemental funding for an HIV Care Innovation activity through either the RWHAP Part D Supplemental (HRSA-18-044) or the Part C Capacity Development opportunity (HRSA-18-051) were allowed to propose an expansion of a previously funded innovation, but HRSA would not pay for the same activity again in FY 2019 if it had already been funded in FY 2018. If an applicant proposed an expansion, they were required to clearly explain how the new project builds on the earlier work and advances the earlier objectives, rather than repeating the prior deliverable.

In terms of who and what the project should target, HRSA emphasized reaching populations disproportionately affected by HIV who also experience poorer health outcomes. Applicants therefore needed to demonstrate that their selected activity would improve access to high quality HIV primary care for underserved people living with HIV, especially women, infants, children, and youth, and that the project would strengthen the organization’s ability to operate effectively in a changing health care landscape. The opportunity was categorized under CFDA 93.153, used a grant funding instrument, and fell under the health funding activity category.

Administratively, the funding opportunity was posted October 15, 2018, with an original application closing date of January 29, 2019. HRSA anticipated making about 35 awards. The public listing showed an award ceiling of $0, which typically signals that the maximum award amount was not specified in the summary field and would instead be described in the full notice or vary based on HRSA’s funding decisions and availability of funds. The eligibility field was listed broadly as "Others" with additional eligibility details referenced as being in the full announcement, indicating that eligibility was likely limited to certain existing RWHAP Part D recipients or otherwise defined entities as described in the complete notice.

• The Department of Health and Human Services, Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "Ryan White HIV/AIDS Program Part D -- Women, Infants, Children, and Youth (WICY) Grants Supplemental Funding" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.153.
• This funding opportunity was created on Oct 15, 2018.
• Applicants must submit their applications by Jan 29, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 35 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for HRSA 19 026

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: